Interdisciplinary Approaches to Influenza Vaccination: Roles of Family Medicine, Nursing, and Medical Administration
Abstract
Background: Influenza remains a major global public health challenge, causing significant annual morbidity and mortality. Its prevention is complicated by the virus's antigenic variability, necessitating annual vaccine updates. Successful vaccination programs require a coordinated, multidisciplinary approach to overcome logistical and educational barriers.
Aim: This article synthesizes the critical roles of various healthcare disciplines in optimizing influenza vaccination coverage. It aims to outline the virological basis for vaccination, evidence-based indications, administration protocols, and the collaborative strategies necessary for effective public health implementation.
Methods: A comprehensive review of influenza virology, vaccine mechanisms (including inactivated, recombinant, and live attenuated platforms), and administration guidelines from bodies like the ACIP and CDC is presented. The analysis focuses on the distinct yet complementary functions of family physicians, nurses, pharmacists, and medical administrators in vaccine delivery, education, and program management.
Results: Influenza vaccination is demonstrated to be safe and effective, with specific formulations recommended for different age groups and risk profiles, such as high-dose vaccines for the elderly. Interprofessional collaboration is shown to be paramount, improving accessibility through pharmacies, ensuring accurate administration and documentation by nurses, and providing clinical oversight and counseling by physicians. This teamwork directly enhances vaccination rates and reduces disease burden.
Conclusion: Maximizing the public health benefit of influenza vaccination hinges on a unified, interdisciplinary strategy. This approach ensures broad coverage, addresses specific population needs, and builds public trust, ultimately reducing the impact of seasonal and pandemic influenza.
Full text article
References
Kirkpatrick E, Qiu X, Wilson PC, Bahl J, Krammer F. The influenza virus hemagglutinin head evolves faster than the stalk domain. Sci Rep. 2018 Jul 11;8(1):10432.
Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season. MMWR Recomm Rep. 2018 Aug 24;67(3):1-20.
Giles ML, Krishnaswamy S, Wallace EM. Maternal immunisation: What have been the gains? Where are the gaps? What does the future hold? F1000Res. 2018;7
Cohen C, Tshangela A, Valley-Omar Z, Iyengar P, Von Mollendorf C, Walaza S, Hellferscee O, Venter M, Martinson N, Mahlase G, McMorrow M, Cowling BJ, Treurnicht FK, Cohen AL, Tempia S. Household Transmission of Seasonal Influenza From HIV-Infected and HIV-Uninfected Individuals in South Africa, 2013-2014. J Infect Dis. 2019 Apr 19;219(10):1605-1615.
Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season. MMWR Recomm Rep. 2022 Aug 26;71(1):1-28.
Franco-Paredes C, Carrasco P, Preciado JI. The first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparedness. J Immune Based Ther Vaccines. 2009 Aug 07;7:2.
Rudenko L, Kiseleva I, Krutikova E, Stepanova E, Rekstin A, Donina S, Pisareva M, Grigorieva E, Kryshen K, Muzhikyan A, Makarova M, Sparrow EG, Torelli G, Kieny MP. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. PLoS One. 2018;13(12):e0208028.
Lim JW, Na W, Kim HO, Yeom M, Park G, Kang A, Chun H, Park C, Oh S, Le VP, Jeong HH, Song D, Haam S. Cationic Poly(Amino Acid) Vaccine Adjuvant for Promoting Both Cell-Mediated and Humoral Immunity Against Influenza Virus. Adv Healthc Mater. 2019 Jan;8(2):e1800953.
Sano K, Ainai A, Suzuki T, Hasegawa H. Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics. Expert Rev Vaccines. 2018 Aug;17(8):687-696.
McAllister L, Anderson J, Werth K, Cho I, Copeland K, Le Cam Bouveret N, Plant D, Mendelman PM, Cobb DK. Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial. Lancet. 2014 Aug 23;384(9944):674-81.
Choi IJ, Kang A, Ahn MH, Jun H, Baek SK, Park JH, Na W, Choi SO. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine. J Control Release. 2018 Sep 28;286:460-466.
Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM., CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007 Feb 15;356(7):685-96.
ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy. Obstet Gynecol. 2018 Apr;131(4):e109-e114.
Bohn-Goldbaum E, Cross T, Leeb A, Peters I, Booy R, Edwards KM. Adverse events following influenza immunization: understanding the role of age and sex interactions. Expert Rev Vaccines. 2022 Mar;21(3):415-422.
Klimek L, Wicht-Langhammer S, von Bernus L, Thorn C, Cazan D, Pfaar O, Hörmann K. [Anaphylactic reactions to vaccines : Chicken egg allergy and the influenza H1N1 vaccination]. HNO. 2017 Oct;65(10):834-839.
Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011 May;127 Suppl 1:S45-53.
Sasaki E, Momose H, Hiradate Y, Mizukami T, Hamaguchi I. Establishment of a novel safety assessment method for vaccine adjuvant development. Vaccine. 2018 Nov 12;36(46):7112-7118.
Del Giudice G, Rappuoli R, Didierlaurent AM. Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. Semin Immunol. 2018 Oct;39:14-21.
Stead M, Critchlow N, Patel R, MacKintosh AM, Sullivan F. Improving uptake of seasonal influenza vaccination by healthcare workers: Implementation differences between higher and lower uptake NHS trusts in England. Infect Dis Health. 2019 Feb;24(1):3-12.
Elbahesh H, Saletti G, Gerlach T, Rimmelzwaan GF. Broadly protective influenza vaccines: design and production platforms. Curr Opin Virol. 2019 Feb;34:1-9.
Bresee JS, McKinlay MA, Abramson J, Klugman KP, Wairagkar N., Global Funders Consortium for Universal Influenza Vaccine Development. Global Funders Consortium for Universal Influenza Vaccine Development. Vaccine. 2019 Jan 07;37(2):211-213.
Authors
Copyright (c) 2024 Mohammed Daefallh Mukmin Alsharari, Malika Mahzry Ghazwany, Abdulmajeed Abdullah Alanazi, Maha Abdullah Saeid Almuwallad, Rayyisah Ali A Rahimi, Fatimah Ahmed B Alsahhari, Abdulaziz Musallam Alsharari, Jawaher Munahi Nukelan Almutairi, Hamad Abdullah Hussein Alyahya, Samar Nasser Alshahrani, Sultan Abdullah Alsaedi, Nader Menwer Abdul Rahman Alrashidi, Muneef Abdulnasser Abdullah Alreshidi, Manal Saad Mohammed Almutairi
This work is licensed under a Creative Commons Attribution 4.0 International License.